A Toronto, Canada venture dedicated to digital wound care announced a digital imaging platform launching to support the industry’s move to decentralized, remote clinical trials. Swift Medical, founded in 2015 to improve the prevention, treatment, and management of wounds, enters the clinical trials market, anticipating growing demand for decentralized, remote data college and management solutions. A smart move, given the post-COVID-19 pandemic’s ongoing shift to decentralized, patient-centric clinical trials—studies increasingly support where and when feasible the treatment of the clinical trial participant in a home-based environment.
The Move to Patient-Centricity
The COVID-19 pandemic has severely impeded clinical trials – making participant recruitment, monitoring, and retention more complex, which has resulted in more expensive, delayed, and sometimes canceled clinical trials. With the implementation of public safety measures, participant access to trial sites was reduced by up to 80% at the onset of the pandemic. Further, as 70% of potential trial participants live over two hours from a trial site, remote clinical trials are vital to improving accessibility and equitab...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).